Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug metabolism and drug transport of the 100 most prescribed oral drugs
Ditte B. Iversen, Nanna Elman Andersen, Ann‐Cathrine Dalgård Dunvald, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 131, Iss. 5, pp. 311-324
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Dietary gallic acid as an antioxidant: A review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions
Zedong Xiang, Huida Guan, Xiang Zhao, et al.
Food Research International (2024) Vol. 180, pp. 114068-114068
Closed Access | Times Cited: 32
Preclinical development of a standardized extract of Ilex paraguariensis A.St.-Hil for the treatment of obesity and metabolic syndrome
Sara Emília Lima Tolouei, Rodrigo Marcon, Fabiana C. Vilela, et al.
Pharmacological Research (2025), pp. 107607-107607
Open Access
Predictive Biomarkers and Personalized Therapy: Use of Pharmacogenetic Testing in a Scandinavian Perspective
Niels Westergaard, Trine Meldgaard Lund, Charlotte Vermehren
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
Mechanisms of Altered Hepatic Drug Disposition during pregnancy: small molecules
Muluneh M. Fashe, Jacqueline B. Tiley, Craig R. Lee
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments
Marakiya T. Moetlediwa, Babalwa Jack, Sithandiwe E. Mazibuko-Mbeje, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2603-2603
Open Access | Times Cited: 4
Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens
Oyinlade Kehinde, Laura B. Ramsey, Andrea Gaedigk, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 1, pp. 69-76
Closed Access | Times Cited: 11
Use of drugs with pharmacogenomics (PGx)‐based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization
Niels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 4, pp. 531-542
Open Access | Times Cited: 3
Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
José J.G. Marı́n, Candela Cives-Losada, Rocı́o I.R. Macı́as, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116166-116166
Open Access | Times Cited: 3
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities
F. Martinelli, Ines Thiele
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
PGRMC1: An enigmatic heme-binding protein
Meredith R. McGuire, Peter J. Espenshade
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108326-108326
Open Access | Times Cited: 17
Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing
Amy Turner, Ashley D. Derezinski, Andrea Gaedigk, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations
Chukwunonso K. Nwabufo
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 2, pp. 89-105
Closed Access | Times Cited: 8
Impact of Pharmacogenomics in Clinical Practice
Nicola Principi, Kyriakoula Petropulacos, Susanna Esposito
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1596-1596
Open Access | Times Cited: 8
A Review of P-Glycoprotein Function and Regulation in Fish
Christina U. Johnston, Christopher J. Kennedy
Fishes (2024) Vol. 9, Iss. 2, pp. 51-51
Open Access | Times Cited: 2
COVID‐19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples
Chukwunonso K. Nwabufo, Jessica G.Y. Luc, Allison McGeer, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 9, pp. 2137-2158
Open Access | Times Cited: 2
The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs
Karolina Wojtowicz, Michał Nowicki
Biochemical and Biophysical Research Communications (2023) Vol. 662, pp. 1-7
Open Access | Times Cited: 7
Using population pharmacokinetic analyses of drugs metabolized by CYP2D6 to study the genotype–phenotype translation
Trine Frederiksen
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 133, Iss. 2, pp. 113-123
Open Access | Times Cited: 6
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes
Ditte B. Iversen, Ann‐Cathrine Dalgård Dunvald, Daniel M. Jespersen, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 434-445
Open Access | Times Cited: 6
SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics
Chunyuan Yang, Limei Guo, Juan Du, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 265-265
Open Access | Times Cited: 1
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 756-763
Open Access | Times Cited: 1
Small molecule drug metabolite synthesis and identification: why, when and how?
Julia Shanu-Wilson, Samuel Coe, Liam Evans, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103943-103943
Open Access | Times Cited: 1
Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters
Chetan P. Kulkarni, Jia Yang, Megan L. Koleske, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 647-647
Open Access | Times Cited: 1
Dicloxacillin is an inducer of intestinal P‐glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users
Ditte B. Iversen, Ann‐Cathrine Dalgård Dunvald, Martin Ernst, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 12, pp. 3252-3262
Open Access | Times Cited: 1
Differences in constitutive gene expression of cytochrome P450 enzymes and ATP-binding cassette transporter gene expression between a susceptible and a highly macrocyclic lactone-resistant Haemonchus contortus isolate in the absence of drug-inducible expression
Natalie Jakobs, Sandro Andreotti, Sabrina Ramünke, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top